Method for the preparation of a stabilized organophosphorous compound solution

US10487020B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10487020-B2
Application numberUS-201615574322-A
CountryUS
Kind codeB2
Filing dateJul 5, 2016
Priority dateJul 28, 2015
Publication dateNov 26, 2019
Grant dateNov 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process involving admixing a ligand and an alkanolamine. The process allows the use of ligand despite the presence of contaminating amounts of phosphorus acid, and improves the shelf life of premixed ligand solutions.

First claim

Opening claim text (preview).

What is claimed is: 1. A process comprising: preparing a solution from raw materials comprising a solvent, an alkanolamine and a ligand raw material comprising a hydrolyzable organophosphorus ligand, wherein degradation by-products in the solution have a total acidity equivalent to at least 200 ppmw phosphorous acid, based on the weight of the ligand, wherein the concentration of alkanolamine in the solution is from 0.025 to 1 wt % based on the total weight of the solution, and wherein the solvent is an aromatic hydrocarbon, an ether, an ester, an aldehyde, and/or an alcohol. 2. The process of claim 1 wherein the ligand raw material is a solid ligand, and comprises greater than 200 ppmw phosphorous acid. 3. The process of claim 1 wherein the solvent comprises an alcohol and/or aldehyde. 4. The process of claim 1 wherein the concentration of the alkanolamine is from 0.2 to 0.7 wt % based on the total weight of the solution. 5. The process of claim 1 wherein the alkanolamine includes at least one compound selected from triethanolamine, triisopropanolamine, methyldiethanolamine, dimethylethanolamine and ethyldiethanolamine. 6. The process of claim 1 wherein the alkanolamine includes at least one compound selected from triethanolamine and triisopropanolamine. 7. The process of claim 1 wherein the alkanolamine is triethanolamine. 8. The process of claim 1 further comprising feeding the ligand solution to a hydroformylation process. 9. The process of claim 8 wherein the hydroformylation process comprises a reaction zone and an extraction zone, and wherein at least a portion of the solution is fed from a mix tank to the reaction zone and/or the extraction zone of the hydroformylation process. 10. The process of claim 8 wherein the solution is fed to the extraction zone. 11. The process of claim 8 wherein the hydroformylation process comprises contacting CO, H 2 , and at least one olefin under hydroformylation conditions sufficient to form at least one aldehyde product in the presence of a catalyst comprising, as components, a transition metal and the hydrolyzable ligand. 12. The process of claim 8 wherein the solution is stored for more than a day before being used in an end use application. 13. The process of claim 8 wherein the solution is stored for more than 3 days before being used in an end use application. 14. The process of claim 8 wherein the solution is stored for a period of at least 30 days before being used in an end use application. 15. The process of claim 1 wherein the solvent has a carboxylic acid content of from 0.02 to 1 weight percent, based on the weight of the solvent. 16. The process of claim 1 , wherein the solution is free of transition metals. 17. A process comprising: preparing a solution from raw materials comprising a solvent, an alkanolamine and a ligand raw material comprising a hydrolyzable organophosphorus ligand, wherein degradation by-products in the solution have a total acidity equivalent to at least 200 ppmw phosphorous acid, based on the weight of the ligand, wherein the concentration of alkanolamine in the solution is from 0.025 to 1 wt % based on the total weight of the solution, and wherein the solvent is xylene, toluene, an ether, an ester, an aldehyde, and/or an alcohol.

Assignees

Inventors

Classifications

  • C07B63/04Primary

    Use of additives {(anti-oxidant compositions or compositions inhibiting chemical change in general C09K15/00)} · CPC title

  • the cyclic phosphorus atom belonging to more than one ring system · CPC title

  • Hydroformylation, metalformylation, carbonylation or hydroaminomethylation · CPC title

  • Phosphites ((RO)3P) , their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof · CPC title

  • with one amino group and at least two hydroxy groups bound to the carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10487020B2 cover?
A process involving admixing a ligand and an alkanolamine. The process allows the use of ligand despite the presence of contaminating amounts of phosphorus acid, and improves the shelf life of premixed ligand solutions.
Who is the assignee on this patent?
Dow Technology Investments Llc
What technology area does this patent fall under?
Primary CPC classification C07B63/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).